(Q74210182)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12039582%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Drugs, leads, and drug-likeness: an analysis of some recently launched drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12039582%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12039582%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12039582%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12039582%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12039582%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

1647-1650

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12039582%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12039582%20AND%20SRC:MED&resulttype=core&format=json

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

A scoring scheme for discriminating between drugs and nondrugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Can we learn to distinguish between "drug-like" and "nondrug-like" molecules?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Properties of known drugs. 2. Side chains

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Drug-like properties and the causes of poor solubility and poor permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Computational methods for the prediction of 'drug-likeness'

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Simple selection criteria for drug-like chemical matter

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Is there a difference between leads and drugs? A historical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

A new probe for heterogeneity in muscarinic receptors: 2-methyl-spiro-(1, 3-dioxolane-4, 3')-quinuclidine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

(+/-) 3-Amino-6-carboxamido-1,2,3,4-tetrahydrocarbazole: a conformationally restricted analogue of 5-carboxamidotryptamine with selectivity for the serotonin 5-HT1D receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Synthesis and anti-ulcer activities of sodium alkylazulene sulfonates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Arteether, a new antimalarial drug: synthesis and antimalarial properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Pharmacological characterization of almotriptan: an indolic 5-HT receptor agonist for the treatment of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Succinimide derivatives. II. Synthesis and antipsychotic activity of N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cis- cyclohexanedicarboximide (SM-9018) and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

1-Naphthylpiperazine derivatives as potential atypical antipsychotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): a new irreversible aromatase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

In vitro and in vivo activities of piritetrate (M-732), a new antidermatophytic thiocarbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Gastric antisecretory effect of FRG-8813, a new histamine H2 receptor antagonist, in rats and dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

Selective class III antiarrhythmic agents. 1 Bis(arylalkyl)amines.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900244-5

7 January 2021

10.1016/S0960-894X(02)00244-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12039582%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference